JP2021520818A5 - - Google Patents

Info

Publication number
JP2021520818A5
JP2021520818A5 JP2020555892A JP2020555892A JP2021520818A5 JP 2021520818 A5 JP2021520818 A5 JP 2021520818A5 JP 2020555892 A JP2020555892 A JP 2020555892A JP 2020555892 A JP2020555892 A JP 2020555892A JP 2021520818 A5 JP2021520818 A5 JP 2021520818A5
Authority
JP
Japan
Prior art keywords
antigenic peptide
pharmaceutical composition
amino acid
immunogenic compound
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020555892A
Other languages
English (en)
Japanese (ja)
Other versions
JP7384819B2 (ja
JP2021520818A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/059329 external-priority patent/WO2019197567A2/en
Publication of JP2021520818A publication Critical patent/JP2021520818A/ja
Publication of JP2021520818A5 publication Critical patent/JP2021520818A5/ja
Priority to JP2023191203A priority Critical patent/JP7670445B2/ja
Application granted granted Critical
Publication of JP7384819B2 publication Critical patent/JP7384819B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020555892A 2018-04-11 2019-04-11 癌の予防及び治療のための抗原性ペプチド Active JP7384819B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023191203A JP7670445B2 (ja) 2018-04-11 2023-11-09 癌の予防及び治療のための抗原性ペプチド

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18305444 2018-04-11
EP18305444.4 2018-04-11
EP2018077512 2018-10-09
EPPCT/EP2018/077512 2018-10-09
PCT/EP2019/059329 WO2019197567A2 (en) 2018-04-11 2019-04-11 Antigenic peptides for prevention and treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023191203A Division JP7670445B2 (ja) 2018-04-11 2023-11-09 癌の予防及び治療のための抗原性ペプチド

Publications (3)

Publication Number Publication Date
JP2021520818A JP2021520818A (ja) 2021-08-26
JP2021520818A5 true JP2021520818A5 (enExample) 2022-04-11
JP7384819B2 JP7384819B2 (ja) 2023-11-21

Family

ID=66092357

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020555892A Active JP7384819B2 (ja) 2018-04-11 2019-04-11 癌の予防及び治療のための抗原性ペプチド
JP2023191203A Active JP7670445B2 (ja) 2018-04-11 2023-11-09 癌の予防及び治療のための抗原性ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023191203A Active JP7670445B2 (ja) 2018-04-11 2023-11-09 癌の予防及び治療のための抗原性ペプチド

Country Status (19)

Country Link
US (2) US12016910B2 (enExample)
EP (2) EP3773689B1 (enExample)
JP (2) JP7384819B2 (enExample)
CN (2) CN120535570A (enExample)
AU (1) AU2019253217B2 (enExample)
BR (1) BR112020020780A2 (enExample)
CA (1) CA3094262A1 (enExample)
DK (1) DK3773689T5 (enExample)
ES (1) ES2935702T3 (enExample)
FI (1) FI3773689T3 (enExample)
HR (1) HRP20230007T1 (enExample)
HU (1) HUE060791T2 (enExample)
LT (1) LT3773689T (enExample)
MX (2) MX2020010701A (enExample)
PL (1) PL3773689T3 (enExample)
RS (1) RS63873B1 (enExample)
SI (1) SI3773689T1 (enExample)
SM (1) SMT202300021T1 (enExample)
WO (1) WO2019197567A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
US11712465B2 (en) 2016-10-07 2023-08-01 Enterome S.A. Microbiota sequence variants of tumor-related antigenic epitopes
IL296165B2 (en) 2016-10-07 2023-10-01 Enterome S A Immunogenic compounds for cancer treatment
CN117801069A (zh) 2016-10-07 2024-04-02 恩特罗姆公司 用于癌症疗法的免疫原性化合物
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
MX2022004598A (es) * 2019-10-16 2022-09-23 Enterome S A Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
PL4021487T3 (pl) * 2019-11-15 2024-04-15 Enterome S.A. Peptydy antygenowe do zapobiegania i leczenia nowotworów złośliwych wywodzących się z limfocytów b
CN111197040B (zh) * 2020-01-21 2023-08-08 福建亿彤生物科技有限公司 壳多糖酶3样蛋白1（chi3l1）抗原表位肽、抗原、抗体、用途及试剂盒
CN114163510B (zh) * 2021-03-24 2024-12-06 深圳市新靶向生物科技有限公司 一种与肝癌驱动基因突变相关的抗原肽组合及其应用
AU2023246941A1 (en) * 2022-03-31 2024-10-24 Enterome S.A. Antigenic peptides for prevention and treatment of cancer.
IT202200006785A1 (it) * 2022-04-06 2023-10-06 Istituto Naz Tumori Irccs Fondazione G Pascale Analoghi di antigeni tumorali da microbiota e usi relativi
KR20240017325A (ko) * 2022-07-29 2024-02-07 주식회사 엘지화학 항원 전달용 재조합 융합 단백질 및 이의 이용

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3841091A1 (de) 1988-12-07 1990-06-13 Behringwerke Ag Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
CA2006700A1 (en) 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
IT1237764B (it) 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
IT1262896B (it) 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
US5550214A (en) 1994-02-10 1996-08-27 Brigham And Women's Hospital Isolated antigenic oncogene peptide fragments and uses
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
CA2366152A1 (en) 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Streptococcus pneumoniae vaccine
WO2000061761A2 (en) 1999-04-09 2000-10-19 Techlab, Inc. Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
EP1189624A4 (en) 1999-06-29 2005-02-23 Epimmune Inc Hla binding peptides and their uses
FR2798128B1 (fr) 1999-09-06 2001-11-16 Inst Nat Sante Rech Med Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla
WO2001058479A1 (en) 2000-02-08 2001-08-16 The Penn State Research Foundation Immunotherapy using interleukin 13 receptor subunit alpha 2
JP2003524016A (ja) 2000-02-23 2003-08-12 エピミューン， インコーポレイテッド Ｈｌａ結合ペプチドおよびそれらの用途
US7892559B2 (en) 2002-01-30 2011-02-22 Survac Aps Survivin-derived peptides and use thereof
CA2480008C (en) 2002-03-22 2015-10-06 The Penn State Research Foundation Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
JP2006512300A (ja) 2002-10-03 2006-04-13 エピミューン インコーポレイテッド Ｈｌａ結合ペプチド及びその使用
CN1954217B (zh) 2004-02-06 2013-05-08 国立健康与医学研究所 衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
WO2006034334A2 (en) 2004-09-21 2006-03-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
US7666622B2 (en) 2005-10-19 2010-02-23 Regeneron Pharmaceuticals, Inc. Monomeric self-associating fusion polypeptides and therapeutic uses thereof
CA2672215A1 (en) 2006-12-11 2008-06-19 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
KR101543624B1 (ko) * 2007-08-20 2015-08-11 온코세라피 사이언스 가부시키가이샤 Ｆｏｘｍ１ 펩티드 및 이를 포함하는 약학적 조성물
PT2119726E (pt) 2008-05-14 2015-03-30 Immatics Biotechnologies Gmbh Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano
US20110182926A1 (en) 2008-08-12 2011-07-28 Nicola La Monica Minigene
ES2536465T3 (es) * 2008-10-01 2015-05-25 Immatics Biotechnologies Gmbh Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
TWI469791B (zh) * 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
US20110033389A1 (en) 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
JP5722334B2 (ja) 2009-11-03 2015-05-20 コリア・ユニバーシティ・リサーチ・アンド・ビジネス・ファウンデーション 酸化亜鉛−結合性ペプチドを含むタンパク質と酸化亜鉛ナノ粒子の複合体及びその用途
GB201004575D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
US9314516B2 (en) 2010-05-04 2016-04-19 Cassian Yee Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses
WO2012027379A2 (en) 2010-08-24 2012-03-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
PT3682905T (pt) 2011-10-03 2022-04-07 Modernatx Inc Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
US20140371302A1 (en) 2011-12-29 2014-12-18 Modema Therapeutics, Inc. Modified mrnas encoding cell-penetrating polypeptides
WO2013151664A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
EP2639299A1 (en) 2012-03-16 2013-09-18 Invectys Universal cancer peptides derived from telomerase
CA2902415C (en) 2012-03-19 2024-02-06 Stemline Therapeutics, Inc. Methods for treating and monitoring the status of cancer
WO2013148147A1 (en) 2012-03-26 2013-10-03 The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
WO2013173411A1 (en) 2012-05-16 2013-11-21 Stemline Therapeutics, Inc Cancer stem cell targeted cancer vaccines
US20140141044A1 (en) 2012-11-12 2014-05-22 Dana-Farber Cancer Institute, Inc. Cord Colitis Syndrome Pathogen
EP2929045B1 (en) 2012-12-05 2020-12-02 SOLA Biosciences LLC Protein expression enhancing polypeptides
JP6548579B2 (ja) 2012-12-06 2019-07-24 ヴィクトリア リンク リミテッド コンジュゲート化合物
GB201315946D0 (en) 2013-09-06 2013-10-23 Immune Targeting Systems Its Ltd Oncology vaccine
AU2015271324B2 (en) 2014-06-06 2019-09-12 Herlev Hospital Determining antigen recognition through barcoding of MHC multimers
WO2016146143A1 (en) 2015-03-16 2016-09-22 Amal Therapeutics Sa Cell penetrating peptides and complexes comprising the same
SG11201706418QA (en) 2015-03-31 2017-10-30 Agency Science Tech & Res Method for antigen loading of dendritic cells and vaccine
SG11201802881YA (en) * 2015-10-08 2018-05-30 Oncotherapy Science Inc Foxm1-derived peptide, and vaccine including same
US12018331B2 (en) 2016-05-23 2024-06-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of diagnosing cancer using cancer testis antigens
IL296165B2 (en) 2016-10-07 2023-10-01 Enterome S A Immunogenic compounds for cancer treatment
CN117801069A (zh) 2016-10-07 2024-04-02 恩特罗姆公司 用于癌症疗法的免疫原性化合物
US11712465B2 (en) 2016-10-07 2023-08-01 Enterome S.A. Microbiota sequence variants of tumor-related antigenic epitopes
AU2018348432B2 (en) 2017-10-09 2025-08-28 Enterome S.A. Microbiota sequence variants of tumor-related antigenic epitopes
US20210106652A1 (en) 2018-04-11 2021-04-15 Enterome S.A. Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
MX2022004598A (es) 2019-10-16 2022-09-23 Enterome S A Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
PL4021487T3 (pl) 2019-11-15 2024-04-15 Enterome S.A. Peptydy antygenowe do zapobiegania i leczenia nowotworów złośliwych wywodzących się z limfocytów b

Similar Documents

Publication Publication Date Title
JP2023179436A5 (enExample)
JP2018509935A5 (enExample)
JP2010506826A5 (enExample)
JP2008530975A5 (enExample)
PT2058323E (pt) Peptídeos associados a tumores de ligação à molécula mhc
JP2008543314A5 (enExample)
RU2015122368A (ru) Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа
JP2008529558A5 (enExample)
HRP20230007T1 (hr) Antigenski peptidi, namijenjeni sprječavanju i liječenju raka
RU2009141595A (ru) Пептиды тем8 и содержащие их вакцины
CA2383737A1 (en) Muc-1 derived peptides
CA2706907C (en) Cancer vaccine composition
JP2010523471A5 (enExample)
WO2016143816A1 (ja) Ｇｐｃ３由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
JP2014502961A5 (enExample)
RU2012147590A (ru) Пептиды cdca5 и содержащие их вакцины
JP2011522777A5 (enExample)
JP2013523084A5 (enExample)
JP2021522239A5 (enExample)
RU2013158399A (ru) Пептиды sema5b и содержащие их вакцины
JP2025124904A5 (enExample)
JP2015529219A5 (enExample)
WO2016056596A1 (ja) Ｈｓｐ７０由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
RU2011150283A (ru) Пептиды ттк и вакцины, их содержащие
JP2012526519A5 (enExample)